Deadly MRSA strain appears partly immune to treatment

The USA600 strain of methicillin-resistant Staphylococcus aureus infects the bloodstream and is five times more lethal than other MRSA strains, and it appears to be partly immune to a drug used to treat it, researchers said. The study found about 50% of patients infected with the strain died within a month.

HealthDay News | 11/01 Bookmark and Share

This story published in AANP SmartBrief on 11/03/2009





More from SmartBrief:

MRSA drug telavancin gains FDA approval

Monday, September 14, 2009

Get stories like these delivered daily for FREE:
AANP SmartBrief
Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues. Learn more